These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32741077)

  • 1. Expression and roles of system L amino acid transporters in human embryonal carcinoma cells.
    Chatsirisupachai K; Kitdumrongthum S; Panvongsa W; Janpipatkul K; Worakitchanon W; Lertjintanakit S; Wongtrakoongate P; Chairoungdua A
    Andrology; 2020 Nov; 8(6):1844-1858. PubMed ID: 32741077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression and functional characterization of system L amino acid transporters in human normal osteoblast cells and osteogenic sarcoma cells.
    Kim SG; Kim HH; Kim HK; Kim CH; Chun HS; Kanai Y; Endou H; Kim DK
    Anticancer Res; 2006; 26(3A):1989-96. PubMed ID: 16827134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription factors Sp1 and p73 control the expression of the proapoptotic protein NOXA in the response of testicular embryonal carcinoma cells to cisplatin.
    Grande L; Bretones G; Rosa-Garrido M; Garrido-Martin EM; Hernandez T; Fraile S; Botella L; de Alava E; Vidal A; Garcia del Muro X; Villanueva A; Delgado MD; Fernandez-Luna JL
    J Biol Chem; 2012 Aug; 287(32):26495-505. PubMed ID: 22718761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Oct-3/4 expression in embryonal carcinoma cells is associated with induction of cisplatin resistance.
    Mueller T; Mueller LP; Luetzkendorf J; Voigt W; Simon H; Schmoll HJ
    Tumour Biol; 2006; 27(2):71-83. PubMed ID: 16557044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Nodal signalling on pluripotency factor expression, tumour cell proliferation and cisplatin-sensitivity in testicular germ cell tumours.
    Harpelunde Poulsen K; Nielsen JE; Grønkær Toft B; Joensen UN; Rasmussen LJ; Blomberg Jensen M; Mitchell RT; Juul A; Rajpert-De Meyts E; Jørgensen A
    BMC Cancer; 2020 Apr; 20(1):349. PubMed ID: 32326899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of two S-nitroso-L-cysteine transporters, which mediate movement of NO equivalents into vascular cells.
    Li S; Whorton AR
    Am J Physiol Cell Physiol; 2007 Apr; 292(4):C1263-71. PubMed ID: 17092994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NANOG controls testicular germ cell tumour stemness through regulation of MIR9-2.
    Cardenas RP; Zyoud A; McIntyre A; Alberio R; Mongan NP; Allegrucci C
    Stem Cell Res Ther; 2024 May; 15(1):128. PubMed ID: 38693576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Heavy Chain 4F2hc Modulates the Substrate Affinity and Specificity of the Light Chains LAT1 and LAT2.
    Kantipudi S; Jeckelmann JM; Ucurum Z; Bosshart PD; Fotiadis D
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine.
    Albany C; Hever-Jardine MP; von Herrmann KM; Yim CY; Tam J; Warzecha JM; Shin L; Bock SE; Curran BS; Chaudhry AS; Kim F; Sandusky GE; Taverna P; Freemantle SJ; Christensen BC; Einhorn LH; Spinella MJ
    Oncotarget; 2017 Jan; 8(2):2949-2959. PubMed ID: 27936464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced proficiency in homologous recombination underlies the high sensitivity of embryonal carcinoma testicular germ cell tumors to Cisplatin and poly (adp-ribose) polymerase inhibition.
    Cavallo F; Graziani G; Antinozzi C; Feldman DR; Houldsworth J; Bosl GJ; Chaganti RS; Moynahan ME; Jasin M; Barchi M
    PLoS One; 2012; 7(12):e51563. PubMed ID: 23251575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of vitamin D on cisplatin sensitivity in testicular germ cell cancer-derived cell lines and in a NTera2 xenograft model.
    Jørgensen A; Blomberg Jensen M; Nielsen JE; Juul A; Rajpert-De Meyts E
    J Steroid Biochem Mol Biol; 2013 Jul; 136():238-46. PubMed ID: 23098692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours.
    Rudolph C; Melau C; Nielsen JE; Vile Jensen K; Liu D; Pena-Diaz J; Rajpert-De Meyts E; Rasmussen LJ; Jørgensen A
    Cell Oncol (Dordr); 2017 Aug; 40(4):341-355. PubMed ID: 28536927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D metabolism and effects on pluripotency genes and cell differentiation in testicular germ cell tumors in vitro and in vivo.
    Blomberg Jensen M; Jørgensen A; Nielsen JE; Steinmeyer A; Leffers H; Juul A; Rajpert-De Meyts E
    Neoplasia; 2012 Oct; 14(10):952-63. PubMed ID: 23097629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin‑resistant germ cell tumor models: An exploration of the epithelial‑mesenchymal transition regulator
    Cardoso IIV; Rosa MN; Moreno DA; Tufi LMB; Ramos LP; Pereira LAB; Silva L; Galvão JMS; Tosi IC; Lengert AVH; Da Cruz MC; Teixeira SA; Reis RM; Lopes LF; Pinto MT
    Mol Med Rep; 2024 Dec; 30(6):. PubMed ID: 39392037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid transport system L is differently expressed in human normal oral keratinocytes and human oral cancer cells.
    Yoon JH; Kim IJ; Kim H; Kim HJ; Jeong MJ; Ahn SG; Kim SA; Lee CH; Choi BK; Kim JK; Jung KY; Lee S; Kanai Y; Endou H; Kim DK
    Cancer Lett; 2005 May; 222(2):237-45. PubMed ID: 15863273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells.
    Kim DK; Kanai Y; Choi HW; Tangtrongsup S; Chairoungdua A; Babu E; Tachampa K; Anzai N; Iribe Y; Endou H
    Biochim Biophys Acta; 2002 Sep; 1565(1):112-21. PubMed ID: 12225859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of amino acid transporter (LAT1 and 4F2hc) in pulmonary pleomorphic carcinoma.
    Kaira K; Kawashima O; Endoh H; Imaizumi K; Goto Y; Kamiyoshihara M; Sugano M; Yamamoto R; Osaki T; Tanaka S; Fujita A; Imai H; Kogure Y; Seki Y; Shimizu K; Mogi A; Shitara Y; Oyama T; Kanai Y; Asao T
    Hum Pathol; 2019 Feb; 84():142-149. PubMed ID: 30300664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of stable cell lines with high expression of heterodimers of human 4F2hc and human amino acid transporter LAT1 or LAT2 and delineation of their differential interaction with α-alkyl moieties.
    Khunweeraphong N; Nagamori S; Wiriyasermkul P; Nishinaka Y; Wongthai P; Ohgaki R; Tanaka H; Tominaga H; Sakurai H; Kanai Y
    J Pharmacol Sci; 2012; 119(4):368-80. PubMed ID: 22850614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. System L amino acid transporter inhibitor enhances anti-tumor activity of cisplatin in a head and neck squamous cell carcinoma cell line.
    Yamauchi K; Sakurai H; Kimura T; Wiriyasermkul P; Nagamori S; Kanai Y; Kohno N
    Cancer Lett; 2009 Apr; 276(1):95-101. PubMed ID: 19058911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of system l amino acid transporter 1 inhibition as a therapeutic target in esophageal squamous cell carcinoma.
    Ohshima Y; Kaira K; Yamaguchi A; Oriuchi N; Tominaga H; Nagamori S; Kanai Y; Yokobori T; Miyazaki T; Asao T; Tsushima Y; Kuwano H; Ishioka NS
    Cancer Sci; 2016 Oct; 107(10):1499-1505. PubMed ID: 27465934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.